STOCKS / Finance

Bristol-Myers Partner Hits 18-Month High On Immuno-Oncology Deal

From News - Investor\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s Business Daily
March 20, 2017 - 12:45pm
Cytomx stock rocketed to a 14-month high Monday, breaking out after the firm expanded its deal with Bristol-Myers Squibb.


Continue reading this article »